Comments on “Jolkinolide B Mitigates Cerebral Ischemia–Reperfusion Injury by Promoting Microglial <scp>M1</scp> / <scp>M2</scp> Polarization Through the <scp>JAK2</scp> / <scp>STAT3</scp> Signaling Pathway”

Authors

Institutions

Publication Details

Journal
CNS Neuroscience & Therapeutics
Published
2026-02-01
DOI
https://doi.org/10.1002/cns.70804
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comments on “Jolkinolide B Mitigates Cerebral Ischemia–Reperfusion Injury by Promoting Microglial M1 / M2 Polarization Through the JAK2 / STAT3 Signaling Pathway”

Lijiang Lv, Kaizheng Wang
CNS Neuroscience & Therapeutics
Neuroinflammation and Neurodegeneration Mechanisms
article

Comments on “Jolkinolide B Mitigates Cerebral Ischemia–Reperfusion Injury by Promoting Microglial M1 / M2 Polarization Through the JAK2 / STAT3 Signaling Pathway”

Lijiang Lv, Kaizheng Wang
article en

Abstract

No abstract available for this paper.
CNS Neuroscience & TherapeuticsVol. 32(2)
The Third Affiliated Hospital of Zhejiang Chinese Medical University (CN), Community Health Center (US)
Openalex Percentile: Top 59%
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comments on “Jolkinolide B Mitigates Cerebral Ischemia–Reperfusion Injury by Promoting Microglial <scp>M1</scp> / <scp>M2</scp> Polarization Through the <scp>JAK2</scp> / <scp>STAT3</scp> Signaling Pathway” — Lijiang Lv, Kaizheng Wang · CNS Neuroscience & Therapeutics (2026) | TGRS Research Map | TGRS